Top 30 medical and healthcare startups in South Korea
Dec 02, 2025
|
Like
28
1
Funding: ₩70.1B
AITRICS develops AI-powered medical software designed to help doctors detect and prevent critical deterioration in patient conditions. Its flagship product, VitalCare, predicts serious adverse events in patients (mortality, unexpected transfer to the intensive care unit, cardiopulmonary resuscitation, sepsis and CPR) by analyzing electronic medical records stored in hospital information systems in real time. The company is also developing V.Doc Pro - physician assistant based on large-scale language models. AITRICS is collaborating with the Mayo Clinic on new medical AI models.
AITRICS develops AI-powered medical software designed to help doctors detect and prevent critical deterioration in patient conditions. Its flagship product, VitalCare, predicts serious adverse events in patients (mortality, unexpected transfer to the intensive care unit, cardiopulmonary resuscitation, sepsis and CPR) by analyzing electronic medical records stored in hospital information systems in real time. The company is also developing V.Doc Pro - physician assistant based on large-scale language models. AITRICS is collaborating with the Mayo Clinic on new medical AI models.
2
Funding: $744M
Celltrion engaged in the research, development, and manufacture of therapeutic proteins.
Celltrion engaged in the research, development, and manufacture of therapeutic proteins.
3
Funding: $561.1M
Lunit is a medical technology company that specializes in developing and providing AI-powered medical imaging solutions. It also provides its infrastructure on military warships.
Lunit is a medical technology company that specializes in developing and providing AI-powered medical imaging solutions. It also provides its infrastructure on military warships.
4
Funding: ₩550B
Lego Chem Bioscience is a company created by people with dreams and enthusiasm for global new drug development
Lego Chem Bioscience is a company created by people with dreams and enthusiasm for global new drug development
5
Funding: $137M
D&D Pharmatech is a biotech company that funds the development of revolutionary medicines through disease-specific subsidiary companies founded and guided by top-tier medical research faculty. This corporate structure creates a unique opportunity to accelerate translation of cutting-edge research into lifesaving therapeutic products for patients. The company’s product pipeline focuses on a range of indications including neurodegenerative and fibrotic diseases.
D&D Pharmatech is a biotech company that funds the development of revolutionary medicines through disease-specific subsidiary companies founded and guided by top-tier medical research faculty. This corporate structure creates a unique opportunity to accelerate translation of cutting-edge research into lifesaving therapeutic products for patients. The company’s product pipeline focuses on a range of indications including neurodegenerative and fibrotic diseases.
7
Funding: $44.6M
Genome & Company is a clinical stage biotechnology company based in Republic of Korea that focuses on discovering and developing the next waves of innovative therapeutics in immuno-oncology through diverse modalities of microbiome, novel target immune checkpoint inhibitors and fusion proteins to fulfill the unmet needs of cancer patients.
Genome & Company is a clinical stage biotechnology company based in Republic of Korea that focuses on discovering and developing the next waves of innovative therapeutics in immuno-oncology through diverse modalities of microbiome, novel target immune checkpoint inhibitors and fusion proteins to fulfill the unmet needs of cancer patients.
9
Funding: $42M
Sky Labs is developing a smart ring-like device called CART (Cardio Tracker) that is capable of diagnoising and managing atrial fibrillation (AF) — a form of heart disease that results in irregular heartbeat rhythms.
Sky Labs is developing a smart ring-like device called CART (Cardio Tracker) that is capable of diagnoising and managing atrial fibrillation (AF) — a form of heart disease that results in irregular heartbeat rhythms.
10
Funding: $37.6M
Ilias Biologics is developing various therapeutic exosomes, a potential treatment for sepsis, pre-term birth, and various hard-to-treat diseases in inflammatory and metabolic areas.
Ilias Biologics is developing various therapeutic exosomes, a potential treatment for sepsis, pre-term birth, and various hard-to-treat diseases in inflammatory and metabolic areas.
11
Funding: ₩48B
NEUROPHET is a medical SW company using advanced neuroscience and AI technologies for better brain treatment. In particular it develops Alzheimer's disease diagnosis platform.
NEUROPHET is a medical SW company using advanced neuroscience and AI technologies for better brain treatment. In particular it develops Alzheimer's disease diagnosis platform.
12
Funding: $24.8M
Medi Whale offers medical AI software for eye disease detection. Its devices assess cardiovascular risk through the use of retinal imagery and artificial intelligence
Medi Whale offers medical AI software for eye disease detection. Its devices assess cardiovascular risk through the use of retinal imagery and artificial intelligence
13
Funding: $23.2M
Atommerce offers a virtual therapy program and a mental health benefits solution for employers.
Atommerce offers a virtual therapy program and a mental health benefits solution for employers.
14
Funding: ₩27B
Aston Sci is a clinical-stage biopharmaceutical company that develops medicines in oncology, immunology, and geriatrics. It's cancer vaccine is being evaluated for breast and gastric cancer
Aston Sci is a clinical-stage biopharmaceutical company that develops medicines in oncology, immunology, and geriatrics. It's cancer vaccine is being evaluated for breast and gastric cancer
15
Funding: $17.9M
Deep Bio combines cutting-edge AI algorithms with digital pathology to revolutionize cancer diagnosis. Deep Bio develops AI prostate cancer diagnosis support software
Deep Bio combines cutting-edge AI algorithms with digital pathology to revolutionize cancer diagnosis. Deep Bio develops AI prostate cancer diagnosis support software
16
Funding: ₩21.7B
ROKIT HEALTHCARE is a leading regenerative medicine biotechnology company. We are committed to pioneering medical treatments based on the principles of 3D bioprinting and autologous stem cell use to regenerate and restore functions of human tissues and organs.
ROKIT HEALTHCARE is a leading regenerative medicine biotechnology company. We are committed to pioneering medical treatments based on the principles of 3D bioprinting and autologous stem cell use to regenerate and restore functions of human tissues and organs.
18
Funding: $16.2M
HoneyNaps develops a bio-signal monitoring device to treat sleep disorders.
HoneyNaps develops a bio-signal monitoring device to treat sleep disorders.
19
Funding: $13.4M
Through use of technology in which measures and modulates brain signals, we develop research protocols that improve cognitive functions. We provide meaningful information retrieved from the wearable devices through analysis of brain signal big data. With this big data, we predict and diagnose the stages of the neurological diseases such as Alzheimer’s disease and mild cognitive impairment.
Through use of technology in which measures and modulates brain signals, we develop research protocols that improve cognitive functions. We provide meaningful information retrieved from the wearable devices through analysis of brain signal big data. With this big data, we predict and diagnose the stages of the neurological diseases such as Alzheimer’s disease and mild cognitive impairment.
20
Funding: ₩15.6B
iMediSync provides automatic brain wave analysis and neuromodulation solutions.
iMediSync provides automatic brain wave analysis and neuromodulation solutions.
